MEMTAB2020 went VIRTUAL
When the Organising Committee postponed MEMTAB2020 from July to December, no one could have predicted what a lasting impact the COVID-19 pandemic would have on our daily and professional lives. Because of the current COVID-19 measures in Belgium and the prospect that the regulations around social distancing will be maintained in the following months, the Organising Commitee has decided to organise MEMTAB2020 as a virtual symposium.
The virtual MEMTAB2020 symposium was hosted on
Thursday 10th and Friday 11th December 2020
The same dates on which the symposium would normally have taken place in Leuven, Belgium
The MEMTAB2020 symposium was hosted by Professor Ben Van Calster, Professor Ann Van den Bruel, Professor Jan Verbakel and the University of Leuven's EPI-Centre, part of the Department of Public Health and Primary Care.
This international symposium attracts researchers, healthcare workers, policy makers and manufacturers actively involved in the development, evaluation or regulation of tests, (bio)markers, models, tools, apps, devices or any other modality used for the purpose of diagnosis, prognosis, risk stratification or (disease or therapy) monitoring.
Accepted abstracts will be published in a supplement to Diagnostic and Prognostic Research.
Diagnostic and Prognostic Research encompasses diagnostic and prognostic research addressing studies on the evaluation of medical tests, markers, prediction models, decision tools and apps. Diagnostic and Prognostic Research provides a platform for disseminating empirical primary studies, systematic reviews (including meta-analyses) as well as articles on methodology, protocols and commentaries addressing diagnostic and prognostic studies. The journal ensures that the results of all well-conducted diagnostic and prognostic research are published, regardless of their outcome.
Professor Ben Van Calster
Professor Ann Van den Bruel
Professor Jan Verbakel
Conference chairs MEMTAB2020 symposium
If you have any questions, please email us at: email@example.com
This international symposium attracts researchers, healthcare workers, policy makers and manufacturers actively involved in the development, evaluation or regulation of tests, (bio)markers, models, tools, apps, devices or any other modality used for the purpose of diagnosis, prognosis, risk stratification or (disease or therapy) monitoring. Rapid technological progress coupled with the significant methodological complexities involved in developing, evaluating and implementing tests, markers, models or devices create formidable challenges. Yet these challenges are matched by unique opportunities, while the wide array of involved subdisciplines create an exciting milieu for the generation of new ideas and directions.
This symposium provides a forum for disseminating knowledge at the forefront of current research, and for stimulating dialogue that will propel future thought and endeavours to tackle the methodological and practical complexities facing the medical diagnostic, prognostic and monitoring field today.
The 2020 event is specifically aimed at bringing together researchers from the diverse reaches of test evaluation, from in vitro test developers, industry and regulatory representatives, through methodologists, guideline developers and practising clinicians, in the hope of improving current understanding through knowledge exchange, and forging our diverse experiences and perspectives to delineate the future direction of diagnostic test research. In this respect, it is the only conference in the world that provides a platform dedicated to the investigation of medical tests, markers, models and other devices used for diagnosis prognosis and monitoring.
MEMTAB2020 is financially supported by:
Dates: 10-11 December 2020
Venue: online (virtual conference)